Category Archives

3 Articles

Cancer

Clay Siegall’s Impact

Posted by JacobT on

NFL free agency is just a few weeks away and teams are working hard to prepare. One of this years biggest names on the market is Redskins quarterback Kirk Cousins. Cousins is clearly the best quarterback available and has been linked to a number of teams. One of those teams is the Cleveland Browns. Clay Siegall recently commented on the possibility of Cousins playing for the Browns. Siegall was quoted as saying ” A Cousins-Browns pairing doesn’t make sense, even for one year.” The Browns have had turmoil in their front office for years. With so many other options in the league like he Jaguars, Giants, and Jets, Siegall’s statement appears to be spot on.

Clay Siegall has been making his presence felt in the business world for quite some time. Siegall is the co-founder of Seattle Genetics and also serves as the the company’s President, CEO. Siegall holds degrees from both George Washington University and the University of Maryland. His resume is impressive and includes working with some well known companies like AbbVie and Pfizer. His work has helped to produce some of the most advanced cancer therapies while generating more than three hundred million dollars.

Clay Siegall is responsible for nearly seventy scientific papers and he holds nine patents. He has served in numerous leadership roles including being a member of the Board of Scientific Counselors for the Cancer Treatment. His work has been recognized several times. He was given the Pierce Award in 1995 for his work with targeted toxins. Just a few years he was a Entrepreneur of the Year award finalist for healthcare. Clay Siegall has a tremendous track record. He is sure to continue making an impact for years to come.

Health/Cancer

Eric Lefkofsky Runs the Best Cancer Company in the World: Tempus

Posted by JacobT on

Eric Lefkofsky is the Chief Executive Officer and co-founder of Tempus, which is a technology company that focuses much on treatment and cure of cancer. He is also the Chairman and co-founder of Groupon, which is a global e-commerce marketplace. Eric has founded many organizations including Uptake Technologies, which is also leading in terms of predictive analysis at world-class industries such as Mediaocean. Mediaocean is a leading provider of integrated media procurement. Echo Global Logistics, a technology-enabled transportation firm is also represented by him among others, i.e., Innerwings that deals with the provision and management without forgetting offering promotional solutions.

The Lefkofsky Family Foundation was laid down in 2006, which is basically a private charitable organization that makes sure the community is served in the best way possible. His wife Liz has always been on his back encouraging him to move forward and keep pressing on. The foundation serves as a Trustee of Lurie Children’s Hospital of Chicago, The Museum of Science and Industry, the Art Institute of Chicago and World Business Chicago.

Eric Lefkofsky is also the Chairman of Board of Trustee of Chicago’s’ Steppenwolf Theatre Company. He is also an author of accelerated Disruption. He graduated from the University of Michigan, where he received his Juris Doctor in Law School. He is said to have donated millions of Dollars in research towards the cure of Cancer in his life. He has now set in new strategies to find the cure for cancer.

Tempus is one of Lefkofsky’s major concerns since it is highly concerned with building infrastructure that will modernize cancer treatment. The company has always worked closely with Lightbank, which has always helped the company in terms of capital and savings. The website that has been created at Tempus gives a clear healthcare guideline on how doctors can attend patients on real-time among others. The website collects large amounts of information and data and thereafter breaking it into pieces for better understanding.

Eric Lefkofsky has always managed the smooth running of the project through committed employees. He has always shown concern for humanity, and, therefore, his ideas run smoothly without any effect.

To Learn More Click This Link : www.tempus.com/about-us/

Cancer Treatment/Cancer

Eric LefkofskyAnd Tempus Help Improve Personalized Breast Cancer Treatment At The University Of Chicago

Posted by JacobT on

Breast cancer patients seeking care at the University of Chicago now have the opportunity to improve the future of treatment plans in addition to improving their own outcomes. The University of Chicago recently announced that it will partner with Tempus to collect and use data for improved planning and keeping patients better informed about their options. Tempus was founded in 2015 by Groupon CEO Eric Lefkofsky and his long-time business partner Brad Keywell. Since then, the company has collected extensive data about many cancer patients to use in an innovative new platform.

How Tempus Works

Tempus works on the premise of recognizing that each person’s cancer is unique. Also, each person’s molecular makeup is different. However, some people have similar genetic profiles cancer mutations. Genetic alterations determine how effective a treatment will be for a person. For example, a treatment that has a high overall success rate for breast cancer patients may not work well for several people who have similar genetic profiles to one another but not to the majority of patients who had success with the popular treatment.

Tempus studies each person’s cancer and then uses several bits of information to match the person to similar profiles. It helps determine treatment worked best for the majority of those people. The technology then suggests treatments for better outcomes for individuals, and doctors at participating health facilities have access to that information. Also, they have access to more detailed data about past studies and other information that is useful to their patients.

How Tempus Started

In recent years, Eric’s wife Elizabeth was diagnosed with breast cancer. Eric spent less time working to support his wife by attending treatment sessions and appointments with her. During her treatment, he noticed that there was little available information about successful breast cancer treatments. The physicians seemed to have limited information as well, and treatment plans were decided based on cumulative success rates rather than success rates connected to individual factors such as a person’s genetic makeup and the cancer’s specific mutations.

Eric thought about Echo Global Logistics, which was a startup of his designed to help personalize and improve logistics for truckers. He thought that a similar structure with a detailed database of information about breast cancer survivors, their extensive genetic information and their treatment plans could be used to devise personalized treatment plans for other cancer patients. He worked with Brad Keywell to develop and launch Tempus. Eric was so confident in success of Tempus that he funded it himself and serves as the CEO. As a self-funded company, Tempus holds advantages over other cancer technology companies. Eric said that Tempus will change cancer treatment for patients the same way Google changed searching for consumers.

How Tempus Will Help University Of Chicago Breast Cancer Patients

Professors, doctors and researchers at the University of Chicago are excited about the new partnership with Tempus. Over 1,000 breast cancer patients will be treated using the advanced technology of Tempus. Patients will be tested to build genetic profiles, and their tumors will be analyzed for specific mutation and growth data. Each person’s combined genetic and cancer data will be matched to existing similar profiles for better treatment options. When physicians present the options to patients, they will also have more detailed information to explain procedures. This will help patients make more informed decisions. Also, breast cancer patients at the University of Chicago will become part of the database of information, which will help future breast cancer patients receive personalized plans for improved outcomes.

The idea is that the database will grow so large over time that genetic and cancer growth profiles will be matched to more specific sets of data, and this will help researchers track trends for fine-tuned research as well. Eric and Brad hope that the technology will assist researchers in finding a cure for breast cancer as well as other forms of cancer. A professor of genetics at the University of Chicago said that although breast cancer is one of the most common cancers, there is only a small amount of information about past successful treatment plans and extensive genetic data for survivors. Researchers at the institution also said that they hope other universities will partner with Tempus to improve personalized cancer care. Northwestern University, the University of Michigan and Rush University Medical Center are just a few of the teaching facilities that are also working with Tempus.

About Eric Lefkofsky

Eric Lefkofsky lives in Chicago with his wife and three children. Eric and his family members are known for their selfless philanthropy, and he is also known for being a successful entrepreneur. He started his career as a carpet salesman while he was attending college at the University of Michigan. After earning his undergraduate degree there, Eric went on to graduate from the University of Michigan Law School. In the 1990s, he and his business partner Brad Keywell started a promotional product company called Starbelly. They sold it in 1999 and moved on to other business ventures.

For the first decade of the 2000s, Eric spent most of his time at InnerWorkings. He co-founded the company, which provided print procurement services for midsize businesses. In 2005, Eric and Brad partnered to start Echo Global Logistics. A year later, the duo founded MediaBank to help advertising buyers plan, finance and execute their programs with a special software program. Eric is most known for being the CEO of Groupon, which was founded in 2009. He did not become CEO until 2013 after the company was sold to investors. Groupon is an online platform for local merchants in various cities to offer discounts and coupons for products or services, and the successful idea has spread across the country quickly.

Eric and Brad started Lightbank in 2010. The company is a capital venture firm for Chicago-based startups. The two also started Uptake in 2014, which is a predictive analysis company. Brad is the CEO of Uptake. Eric stepped down as CEO of Groupon in 2015 but still holds the role of chairman. He now spends most of his time as CEO of Tempus. In his spare time, Eric enjoys spending time with his family. Brad and his wife Elizabeth started the Lefkofsky Family Foundation in 2006. The organization supports scientific, educational and charitable causes around the globe. There is special funding for human rights and education groups that improve the quality of life in needy communities, and the couple donate a considerable amount of money to Chicago-based education and science programs each year.